Fibromyalgia, Migraines, PTSD: Brain Circuit Connection
Unraveling the Neural Basis of Suffering: New Pathway Links Pain Signals to Emotional Distress
For centuries, philosophers and scientists have grappled with a essential question: what distinguishes the mere detection of physical pain from the profound suffering it can inflict? Now, a groundbreaking study by researchers at the Salk Institute has identified a novel neural pathway in mice that directly links pain signals to the brain’s emotional processing centers, offering a molecular and circuit-level clarification for this enduring mystery.
The long-standing debate about the nature of pain has inspired han and his team to revisit the question using modern research tools. By employing advanced techniques to precisely manipulate the activity of specific brain cells, the researchers uncovered a previously unknown spinothalamic pathway. This circuit transmits pain signals from the spinal cord to a distinct region of the thalamus, a key relay station in the brain. Crucially, this thalamic area has direct connections to the amygdala, the brain’s primary center for processing emotions.The specific neurons involved in this pathway are identifiable by their expression of CGRP (calcitonin gene-related peptide),a neuropeptide originally discovered in Professor Ronald Evans’ lab at Salk.In their experiments, when the researchers genetically silenced these CGRP-expressing neurons in mice, the animals still reacted to basic pain stimuli like heat or pressure, indicating their sensory processing remained intact.Though, these mice failed to associate negative feelings with these experiences, exhibiting no learned fear or avoidance behaviors in subsequent trials. Conversely, when these same neurons were artificially activated using optogenetics, the mice displayed clear signs of distress and learned to avoid the previously stimulated areas, even in the absence of any actual pain.
“pain processing is not just about nerves detecting pain; it’s about the brain deciding how much that pain matters,” explains Sukjae kang, the study’s first author and a senior research associate in Han’s lab. “Understanding the biology behind these two distinct processes will help us find treatments for the kinds of pain that don’t respond to traditional drugs.”
This discovery holds significant implications for understanding and treating chronic pain conditions such as fibromyalgia and migraines. These disorders are characterized by prolonged, intense, and unpleasant pain experiences, frequently enough without a clear physical cause or injury.Many patients also report extreme sensitivity to stimuli that others would not perceive as painful, such as light, sound, or touch.
Professor Han suggests that overactivation of the CGRP spinothalamic pathway may contribute to these conditions by causing the brain to misinterpret or overreact to sensory inputs.Indeed, transcriptomic analysis of these CGRP neurons revealed the expression of numerous genes associated with migraines and other pain disorders. This finding is notably relevant given that several CGRP blockers are already in clinical use for migraine treatment, suggesting this pathway’s role in the condition and potentially inspiring new non-addictive therapies for affective pain disorders.
Furthermore, Han sees potential relevance for psychiatric conditions marked by heightened threat perception, such as Post-Traumatic Stress Disorder (PTSD). Emerging evidence from his lab indicates that the CGRP affective pain pathway functions as part of the brain’s broader alarm system, responding not only to pain but also to a wide range of unpleasant sensations. Modulating this pathway with CGRP blockers could offer a novel therapeutic approach to alleviate fear, avoidance, and hypervigilance in trauma-related disorders.
However, the precise relationship between the CGRP pathway and the psychological pain associated with social experiences like grief, loneliness, and heartbreak remains an open question requiring further examination.
“Our discovery of the CGRP affective pain pathway gives us a molecular and circuit-level explanation for the difference between detecting physical pain and suffering from it,” states Han. “We are excited to continue exploring this pathway and enabling future therapies that can reduce this suffering.”
The research was supported by grants from the National Institute of Mental Health and the Simons Foundation. Other contributing authors include Shijia liu, Jong-Hyun Kim, Dong-Il Kim, Tae Gyu Oh, Jiahang Peng, Mao Ye, Kuo-Fen Lee, Ronald M. Evans, and Martyn Goulding of Salk.